Analyzing the effects of low molecular weight heparin on blood pressure levels,thrombin time,prothrombin time,and partially activated prothrombin time in patients with gestational hypertension
Objective To explore the effects of low molecular weight heparin on blood pressure levels and major coagulation indicators in patients with gestational hypertension.Methods 76 patients with gestational hypertension in our hospital were selected and randomly divided into an research group and a control group using a random number table method,with 38 cases in each group.The control group received routine treatment,while the research group received treatment with low molecular weight heparin in addition to routine treatment.The blood pressure levels and coagulation function indicators before and after treatment were compared between the two groups.Results The total effective rate of the research group was 97.37％,which was higher than the control group's 84.21％,and the difference was statistically significant(P＜0.05);After treatment,the levels of systolic and diastolic blood pressure in the study group were lower than those in the control group(P＜0.05);After treatment,the study group had longer thrombin time,prothrombin time,and partially activated prothrombin time than the control group(P＜0.05);The incidence of cesarean section,premature birth,neonatal asphyxia,and postpartum hemorrhage in the research group was lower than that in the control group(P＜0.05);The incidence of adverse drug reactions in the research group was 5.26％,while in the control group it was 7.89％,with no statistically significant difference(P＞0.05).Conclusion For patients with gestational hypertension,administering low-molecular-weight heparin during treatment can achieve definite therapeutic effects,help improve overall treatment efficiency,better control patient blood pressure levels,improve coagulation function indicators,and improve pregnancy outcomes and medication safety.
NETL
NSTL
万方数据
